Guidelines

1. Eligibility & Registration

• Registration Requirement: Only registered delegates will be allowed to submit abstracts. Submission must be done exclusively via the official conference website only.
• Originality: Submissions must be original work not previously published or presented at National or International meetings.
  • Note: Presentations previously shared at Local or State levels are permitted but must be declared during submission.
• Limit per Author: A presenting author may submit a maximum of two oral presentations and two e-posters. Do not submit the same abstract under multiple categories.

2. Formatting & Technical Specifications

• Word Limit: Maximum 250 words.
• Language & Font: Must be in English using Times New Roman font.
• Title Rules: Use Sentence case (e.g., Clinical study of...). Keep it concise, avoid abbreviations in the title, and do not use all capital letters.
• Graphics:
  • Do not include tables, graphs, or references within the text.
  • Recommended: Submit a single JPG file of a “Graphic Abstract” via the designated upload option. (Graphic abstract is recommended but not compulsory)
• Style: Use numerals for numbers (unless starting a sentence). Use generic drug names only; avoid commercial/brand names.
• Declare conflict of interest, if any.

3. Structure & Content

Choose the appropriate structure based on your submission type:

• Original Research: 1) Background, 2) Aims & Objectives, 3) Materials & Methods, 4) Results, Limitations, & Conclusions. (Results must be included).
• Case Reports/Series: 1) Introduction, 2) Case Report/Series, 3) Discussion.
• Avoid Vague Statements: Do not use phrases like “the results will be discussed.” Be specific.

4. Ensuring Blinded Review

To maintain a fair review process:

• Do not include names of authors, collaborators, hospitals, colleges, or locations within the title or abstract body.
• Author affiliations must be entered separately in the online form fields provided.
• Award Papers: Stricter anonymity applies; ensure no mention of institutions or co-authors is present.

5. Important Deadlines & Policy

• Submission Deadline: 31st July 2026.
• Notification of Acceptance: 31th October 2026.
• Correspondence: The first author will be the primary contact. Please ensure your email and mobile number are accurate.
• Copyright: By submitting, authors transfer copyright to the Organizing Committee for publication in print or electronic media.
• Compliance: Non-adherence to these guidelines may result in automatic rejection.

6. Change of Presenting Author

• Any change in the presenting author of an accepted abstract will be considered only upon personal communication from the primary author to the Scientific Secretary, at least one month in advance.
• The new presenting author must be a co-author registered at the time of abstract submission.
• The co-author must also be a registered delegate of Dermacon2027 to present the paper.

7. Withdrawal of Abstract

• Once accepted and communicated by the Scientific Committee, an abstract may be withdrawn only under exceptional circumstances, following direct communication with the Committee.
• Withdrawal requests must be submitted within 15 days of communication of the abstract evaluation result.

8. Additional Provisions

• The Scientific Committee reserves the right to change the category of an abstract (e.g., from award paper to free paper or e-poster).
• Such changes will be communicated to the primary author at the conclusion of the evaluation process.
• The decision of the Scientific Committee shall be final and binding on all matters related to abstracts.

Queries and Feedback

For any queries or feedback, please contact: Email: abstract@dermacon2027.com

Click Here to Submit Your Abstract Step-by-Step Guide